Lobbying Activity Report

3532-42938

Organization: Novo Nordisk Canada Inc.
Associated registration: 9743-3532-8
Lobbying Activity date: 2025-05-16
Arranged a meeting: No
Posted date: 2025-06-06

In-house lobbyists who participated in the lobbying activity: Dan Ekstrand
Senior Public Office Holders who were lobbied in this activity: Ian Rongve, ADM
Pharmaceutical, Laboratory & Blood Services Division, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Policy and program discussions from a broader innovative manufacturer industry perspective regarding the government's delivery of health care and/or access to appropriate/approved medications.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Economic Development and Trade, Finances and Budgets, Health, Hospitals
 
Senior officer who filed this Lobbying Activity Report: Vince Lamanna
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Return to Registration for Yellowstone to Yukon Conservation Initiative Foundation
Date Modified: